These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

363 related articles for article (PubMed ID: 30513872)

  • 1. HGF/c-MET Signaling in Melanocytes and Melanoma.
    Czyz M
    Int J Mol Sci; 2018 Dec; 19(12):. PubMed ID: 30513872
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Met and hepatocyte growth factor/scatter factor signal transduction in normal melanocytes and melanoma cells.
    Halaban R; Rubin JS; Funasaka Y; Cobb M; Boulton T; Faletto D; Rosen E; Chan A; Yoko K; White W
    Oncogene; 1992 Nov; 7(11):2195-206. PubMed ID: 1331934
    [TBL] [Abstract][Full Text] [Related]  

  • 3. c-Met autocrine activation induces development of malignant melanoma and acquisition of the metastatic phenotype.
    Otsuka T; Takayama H; Sharp R; Celli G; LaRochelle WJ; Bottaro DP; Ellmore N; Vieira W; Owens JW; Anver M; Merlino G
    Cancer Res; 1998 Nov; 58(22):5157-67. PubMed ID: 9823327
    [TBL] [Abstract][Full Text] [Related]  

  • 4. met and HGF-SF in normal melanocytes and melanoma cells.
    Halaban R; Rubin JS; White W
    EXS; 1993; 65():329-39. PubMed ID: 8380740
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatocyte growth factor/scatter factor-MET signaling in neural crest-derived melanocyte development.
    Kos L; Aronzon A; Takayama H; Maina F; Ponzetto C; Merlino G; Pavan W
    Pigment Cell Res; 1999 Feb; 12(1):13-21. PubMed ID: 10193678
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Downregulation of E-cadherin and Desmoglein 1 by autocrine hepatocyte growth factor during melanoma development.
    Li G; Schaider H; Satyamoorthy K; Hanakawa Y; Hashimoto K; Herlyn M
    Oncogene; 2001 Dec; 20(56):8125-35. PubMed ID: 11781826
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatocyte growth factor/MET in cancer progression and biomarker discovery.
    Matsumoto K; Umitsu M; De Silva DM; Roy A; Bottaro DP
    Cancer Sci; 2017 Mar; 108(3):296-307. PubMed ID: 28064454
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quercetin inhibits HGF/c-Met signaling and HGF-stimulated melanoma cell migration and invasion.
    Cao HH; Cheng CY; Su T; Fu XQ; Guo H; Li T; Tse AK; Kwan HY; Yu H; Yu ZL
    Mol Cancer; 2015 May; 14():103. PubMed ID: 25971889
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Up-regulation of MET expression by alpha-melanocyte-stimulating hormone and MITF allows hepatocyte growth factor to protect melanocytes and melanoma cells from apoptosis.
    Beuret L; Flori E; Denoyelle C; Bille K; Busca R; Picardo M; Bertolotto C; Ballotti R
    J Biol Chem; 2007 May; 282(19):14140-7. PubMed ID: 17371876
    [TBL] [Abstract][Full Text] [Related]  

  • 10. c-Met expression is regulated by Mitf in the melanocyte lineage.
    McGill GG; Haq R; Nishimura EK; Fisher DE
    J Biol Chem; 2006 Apr; 281(15):10365-73. PubMed ID: 16455654
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Co-expression of hepatocyte growth factor and c-Met predicts peritoneal dissemination established by autocrine hepatocyte growth factor/c-Met signaling in gastric cancer.
    Toiyama Y; Yasuda H; Saigusa S; Matushita K; Fujikawa H; Tanaka K; Mohri Y; Inoue Y; Goel A; Kusunoki M
    Int J Cancer; 2012 Jun; 130(12):2912-21. PubMed ID: 21796631
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatocyte Growth Factor-c-MET Signaling Mediates the Development of Nonsensory Structures of the Mammalian Cochlea and Hearing.
    Shibata S; Miwa T; Wu HH; Levitt P; Ohyama T
    J Neurosci; 2016 Aug; 36(31):8200-9. PubMed ID: 27488639
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Role of MET in Melanoma and Melanocytic Lesions.
    Zhou Y; Song KY; Giubellino A
    Am J Pathol; 2019 Nov; 189(11):2138-2148. PubMed ID: 31476283
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The HGF-cMET signaling pathway in conferring stromal-induced BRAF-inhibitor resistance in melanoma.
    Filitis DC; Rauh J; Mahalingam M
    Melanoma Res; 2015 Dec; 25(6):470-8. PubMed ID: 26317169
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of uveal melanoma interconverted phenotype by hepatocyte growth factor/scatter factor (HGF/SF).
    Hendrix MJ; Seftor EA; Seftor RE; Kirschmann DA; Gardner LM; Boldt HC; Meyer M; Pe'er J; Folberg R
    Am J Pathol; 1998 Apr; 152(4):855-63. PubMed ID: 9546344
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Involvement of PI3K/Akt signaling pathway in hepatocyte growth factor-induced migration of uveal melanoma cells.
    Ye M; Hu D; Tu L; Zhou X; Lu F; Wen B; Wu W; Lin Y; Zhou Z; Qu J
    Invest Ophthalmol Vis Sci; 2008 Feb; 49(2):497-504. PubMed ID: 18234991
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gene of the month: HGF.
    Fajardo-Puerta AB; Mato Prado M; Frampton AE; Jiao LR
    J Clin Pathol; 2016 Jul; 69(7):575-9. PubMed ID: 27072686
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activated Hgf-Met Signaling Cooperates with Oncogenic BRAF to Drive Primary Cutaneous Melanomas and Angiotropic Lung Metastases in Mice.
    Braun AD; Mengoni M; Bonifatius S; Tüting T; Gaffal E
    J Invest Dermatol; 2020 Jul; 140(7):1410-1417.e2. PubMed ID: 31972251
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatocyte growth factor and melanoma: gene transfer studies in human melanocytes.
    Hamoen KE; Borel Rinkes IH; Morgan JR
    Melanoma Res; 2001 Apr; 11(2):89-97. PubMed ID: 11333132
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The potential therapeutic and prognostic impacts of the c-MET/HGF signaling pathway in colorectal cancer.
    Parizadeh SM; Jafarzadeh-Esfehani R; Fazilat-Panah D; Hassanian SM; Shahidsales S; Khazaei M; Parizadeh SMR; Ghayour-Mobarhan M; Ferns GA; Avan A
    IUBMB Life; 2019 Jul; 71(7):802-811. PubMed ID: 31116909
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.